mouse model

• A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.
• A novel, ataxic mouse model of Ataxia Telangiectasia caused by a clinically relevant nonsense mutation
• Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.
• The impact of glutamine supplementation on the symptoms of ataxia-telangiectasia: a preclinical assessment.